Skip to main content
VCbacked
Log inGet Started

CHAIN Biotechnology

Marlow, United Kingdom

CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.

$2.3M raised
Jul 2023
Seed
BiotechnologyHealth CareMedical

Top Investors

Business Growth FundInnovate UKFuture Planet CapitalUK Innovation & Science Seed FundSynBioVen

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CHAIN Biotechnology

How much funding has CHAIN Biotechnology raised?
CHAIN Biotechnology has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in July 2023.
Who are CHAIN Biotechnology's investors?
CHAIN Biotechnology's investors include Business Growth Fund, Innovate UK, Future Planet Capital, UK Innovation & Science Seed Fund, SynBioVen.
Where is CHAIN Biotechnology headquartered?
CHAIN Biotechnology is headquartered in Marlow, United Kingdom.
What does CHAIN Biotechnology do?
CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.
What stage is CHAIN Biotechnology at?
CHAIN Biotechnology is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CHAIN Biotechnology — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/chain-biotechnology. Accessed June 17, 2026.
APA
VCBacked. (2023). CHAIN Biotechnology — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/chain-biotechnology
Wikipedia (cite web)
{{cite web |title=CHAIN Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/chain-biotechnology |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong